Xudong Tang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Emergency Department

Reactive Oxygen Species

Ulcerative Colitis

Radiation Induced

Top Venues

Nature communications

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Xudong Tang, Yangyang Shang, Hong Yang, Yalan Song, Shan Li, Yusi Qin, Jingyi Song, Kang Chen, Yang Liu, Dinglin Zhang, Lei Chen
Targeted delivery of Fc-fused PD-L1 for effective management of acute and chronic colitis. Nature communications 15 (1) (2024)
Xudong Tang, Yangyang Shang, Hong Yang, Yalan Song, Shan Li, Yusi Qin, Jingyi Song, Kang Chen, Yang Liu, Dinglin Zhang, Lei Chen
Targeted delivery of Fc-fused PD-L1 for effective management of acute and chronic colitis. Nature communications 15 (1) (2024)
Xudong Tang, Yangyang Shang, Hong Yang, Yalan Song, Shan Li, Yusi Qin, Jingyi Song, Kang Chen, Yang Liu, Dinglin Zhang, Lei Chen
Targeted delivery of Fc-fused PD-L1 for effective management of acute and chronic colitis. Nature communications 15 (1) (2024)
Xudong Tang, Yangyang Shang, Hong Yang, Yalan Song, Shan Li, Yusi Qin, Jingyi Song, Kang Chen, Yang Liu, Dinglin Zhang, Lei Chen
Targeted delivery of Fc-fused PD-L1 for effective management of acute and chronic colitis. Nature communications 15 (1) (2024)
Yao Wei, Xiaoxin Ren, Phillip M Galbo, Scott Moerdler, Hao Wang, R Alejandro Sica, Bijan Etemad-Gilbertson, Lei Shi, Liqiang Zhu, Xudong Tang, Qi Lin, Mou Peng, Fangxia Guan, Deyou Zheng, Jordan M Chinai, Xingxing Zang
KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target. Science immunology 6 (61) (2022)